Listed

Dianthus Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 9, 2018 and accepted by EDGAR at Aug 9, 2018, 16:21 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-04-01 to 2018-06-30$0us-gaap:Revenues
Revenue6 months2018-01-01 to 2018-06-30$0us-gaap:Revenues
Research and development3 months2018-04-01 to 2018-06-30$9.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$17.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-04-01 to 2018-06-30−$14.0mus-gaap:OperatingIncomeLoss
Operating income6 months2018-01-01 to 2018-06-30−$25.3mus-gaap:OperatingIncomeLoss
Income tax3 months2018-04-01 to 2018-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-01-01 to 2018-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-04-01 to 2018-06-30−$13.7mus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30−$24.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30−$3.13us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30−$7.25us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2018-01-01 to 2018-06-30−$18.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-01-01 to 2018-06-30$846.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-06-30$173.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-06-30$175.9mus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$180.6mus-gaap:Assets
Current liabilitiesAt period end2018-06-30$7.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-06-30$8.4mus-gaap:Liabilities
Shareholders' equityAt period end2018-06-30$172.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-18-244360. Last ingested by Listed: Nov 13, 2026, 16:49 ET. Listed shows no prices and gives no investment advice.